Skip to main content

Caris Biorepository Research Protocol

Recruiting · NCT01499394

Conditions: Cancer, Early Detection of Cancer, Minimal Residual Disease

At a glance

Research payments reported, 2025
$715,325
U.S. investigators named
28
Sites paid
28
Planned or actual enrollment
100,000

About the trial

Sponsor
Caris Science, Inc.
Dates
Started 2010-11; completion 2035-11
Results posted
Not yet

The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.

From ClinicalTrials.gov, last updated 2026-01-21. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Caris Mpi, Inc. reported $715,325 in research payments for this study in 2025 (80 payments).

Products named: Mi Cancer Seek

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.